Behçet's disease is a chronic, relapsing inflammatory disorder of unknown etiology, characterized by a triad of recurrent aphthous stomatitis, genital ulceration, and uveitis, along with cardiovascular, pulmonary, gastrointestinal, and nervous system involvement.
CASE REPORT
A 22-year-old male patient was admitted with one-week of headache, vomiting, and urinary incontinence. Before admission, he had felt motor weakness for two years and noticed recurrent genital and oral ulcers with a frequency of more than three episodes per year for five years. He had no visual impairment. There were no cutaneous lesions such as papules, macules, ecchymosis or nodules. The pathergy test was positive. On neurological examination, he had impaired muscle strength in the upper (phase-4 on both sides) and lower (phase-4 in the left and phase-3 in the right) extremities. His impairment level according to American Spinal Injury Association classification was D. He was able to walk only by assistance from his parents or a walking stick. Pathological reflexes such as the Hoffmann and Babinski signs were present bilaterally. Abdominal reflex, cremasteric reflex, tendon reflexes disappeared bilaterally. He had a sensory level at C2 on the right and T 2 on the left. Routine biochemical tests showed an increased erythrocyte sedimentation rate (85 mm/h) and C-reactive protein level (124 mg/L). Intravenous methylprednisolone (120 mg/day) was administered for three days, followed by an oral administration of prednisolone (45 mg/day). In conjunction with the steroid therapy, intravenous cyclophosphamide (0.4 g) was administered twice. There was rapid regression in his complaints after half a month of therapy. He was able to control his bladder and had increased muscle strength in his lower limbs (phase 4+ in both). He was able to walk by himself without any assistance. Routine biochemical tests showed decreased erythrocyte sedimentation rate (4 mm/h) and C-reactive protein (6 mg/L). Cells and protein in CSF decreased to 20/uL and 311.5 mg/L, respectively. The patient was neurologically stable after three months of follow-up.
DISCUSSION
This patient fulfills diagnostic criteria for Behçet's disease. 3 In NBD, the central nervous system might be involved in one or both of two ways: first, through the development of an immune mediated meningoencephalitis, and second, as a consequence of thrombosis within the dural venous sinuses. 4 The most common manifestations of NBD are fever, headache, motor weakness, and cranial nerve palsy and there is a low prevalence of behavioral changes, seizures, and sphincter incontinence. Prognosis of NBD is far from optimistic. 4 For patients with poor prognostic factors such as multifocal involvement, spinal presentations, more than two attacks per year, progressive course, and increased CSF cell count and protein content at the time of neurologic manifestations, intravenous cyclophosphamide and corticosteroids are recommended. 5 If these regimens fail, biologics should be added. 6 Most nonresponders to cyclophosphamide and corticosteroids are recalcitrant or refractory cases. 7, 8 This high-risk patient responded well to the immunosuppressive therapy approximately in a period of 15 days. To the best of our knowledge, in the literature, there is another case of NBD with longitudinally extensive transverse myelitis who achieved marked clinical improvements after treatment with intravenous and oral steroids followed by six months of pulsed intravenous cyclophosphamide. 9 Spinal cord involvement in NBD is not frequently encountered, and longitudinal myelitis is rare, which has to be differentiated from other pathologies such as multiple sclerosis, central nervous system lupus, acute disseminated encephalomyelitis, central nervous system lymphoma, and neuromyelitis optica. 10, 11 Neuro-Behçet's disease associated longitudinal myelitis is really rare. Magnetic resonance imaging is useful for its diagnosis. Corticosteroid and 
